文献速递肝胆胰外科围术期管理与 ERAS

肝门部胆管癌大范围肝切除术后并发症与死亡率:系统综述与Meta分析

Morbidity and mortality after major liver resection in patients with perihilar cholangiocarcinoma: A systematic review and meta-analysis.
PubMed 文献 · Surgery · 2019-03-11

该系统综述与Meta分析纳入51项研究、4634例肝门部胆管癌大范围肝切除患者,汇总30天和90天死亡率分别为5%和9%,总体并发症和严重并发症分别为57%和40%。西方研究相比亚洲研究30天死亡率(8% vs 2%)、90天死亡率(12% vs 3%)及总体并发症(63% vs 54%)显著更高,校正医院规模后死亡率差异仍显著。

要点

  • 肝门部胆管癌大范围肝切除术后30天和90天死亡率分别为5%和9%。
  • 总体并发症57%,严重并发症40%,处于较高水平。
  • 西方系列死亡率显著高于亚洲系列,校正医院规模后仍显著。

核心结论

  • 肝门部胆管癌大范围肝切除术后并发症与死亡率均较高。
  • 西方系列死亡率高于亚洲系列,校正医院规模后差异仍显著。
  • 需要标准化报告结局,并进一步分析东西方中心结局差异的原因。

研究设计与样本

  • 共纳入51项研究,代表4634例患者。
  • 采用随机效应模型进行Meta分析和Meta回归,并评估偏倚风险。

主要发现

  • 汇总30天死亡率为5%(95%CI 3%-6%),90天死亡率为9%(95%CI 6%-12%)。
  • 汇总总体并发症为57%(95%CI 50%-64%),严重并发症为40%(95%CI 34%-47%)。
  • 西方研究相比亚洲研究30天死亡率8% vs 2%(P < .001),90天死亡率12% vs 3%(P < .001),总体并发症63% vs 54%(P = .048)。
  • 校正医院规模后,西方与亚洲系列死亡率差异仍显著。
  • 单因素Meta回归显示医院规模对死亡率或并发症无影响,但校正地理位置后,更高医院规模与更高严重并发症相关(P = .039)。

临床怎么用

  • 应告知患者肝门部胆管癌大范围肝切除术后并发症和死亡风险较高。
  • 关注东西方中心结局差异,治疗策略可能影响结局。
  • 推荐标准化报告术后结局以便比较。

局限性

  • 研究为系统综述与Meta分析,纳入研究间存在异质性。
  • 未明确报告偏倚风险评估的具体结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Morbidity and mortality after hepatectomy for perihilar cholangiocarcinoma are known to be high. However, reported postoperative outcomes vary, with notable differences between Western and Asian series. We aimed to determine morbidity and mortality rates after major hepatectomy in patients with perihilar cholangiocarcinoma and assess differences in outcome regarding geographic location and hospital volume. METHODS: A systematic review was performed by searching the MEDLINE and EMBASE databases through November 20, 2017. Risk of bias was assessed and meta-analysis and metaregression were performed using a random effects model. RESULTS: A total of 51 studies were included, representing 4,634 patients. Pooled 30-day and 90-day mortality were 5% (95% CI 3%-6%) and 9% (95% CI 6%-12%), respectively. Pooled overall morbidity and severe morbidity were 57% (95% CI 50%-64%) and 40% (95% CI 34%-47%), respectively. Western studies compared with Asian studies had a significantly higher 30-day mortality, 90-day mortality, and overall morbidity: 8% versus 2% (P < .001), 12% versus 3% (P < .001), and 63% versus 54% (P = .048), respectively. This effect on mortality remained significant after correcting for hospital volume. Univariate metaregression analysis showed no influence of hospital volume on mortality or morbidity, but when corrected for geographic location, higher hospital volume was associated with higher severe morbidity (P = .039). CONCLUSION: Morbidity and mortality rates after major hepatectomy for perihilar cholangiocarcinoma are high. The Western series showed a higher mortality compared with the Asian series, even when corrected for hospital volume. Standardized reporting of outcomes is necessary. Underlying causes for differences in outcomes between Asian and Western centers, such as differences in treatment strategies, should be further analyzed.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Franken LC, Schreuder AM, Roos E, et al. Morbidity and mortality after major liver resection in patients with perihilar cholangiocarcinoma: A systematic review and meta-analysis. Surgery. 2019. PMID: 30871811. doi:10.1016/j.surg.2019.01.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。